{"nct_id":"NCT02953509","title":"Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2016-11-21","start_date_type":"ACTUAL","primary_completion_date":"2024-03-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}